Shigesaburo Miyakoshi
Overview
Explore the profile of Shigesaburo Miyakoshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oshima S, Arai Y, Kondo T, Yano S, Hirabayashi S, Uchida N, et al.
Bone Marrow Transplant
. 2025 Jan;
PMID: 39838078
Umbilical cord blood transplantation (CBT) is accepted as an effective treatment for acute myeloid leukemia (AML), and reduced-intensity conditioning (RIC), rather than myeloablative conditioning (MAC) regimens allowed elderly patients to...
2.
Shimomura Y, Kitamura T, Yanada M, Mizuno S, Kondo T, Yoshihara S, et al.
Cytotherapy
. 2024 Dec;
27(3):316-323.
PMID: 39625431
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment option for patients with refractory and relapsed acute myeloid leukemia (R/R AML) not in complete remission. Many...
3.
Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation
Kuwatsuka Y, Kasajima R, Yamaguchi R, Uchida N, Konuma T, Tanaka M, et al.
Transplant Cell Ther
. 2024 Feb;
30(4):444.e1-444.e11.
PMID: 38336299
Delayed neutrophil recovery is an important limitation to the administration of cord blood transplantation (CBT) and leaves the recipient vulnerable to life-threatening infection and increases the risk of other complications....
4.
Kobayashi M, Kobayashi S, Hayashi T, Tachibana M, Saito T, Ogura K, et al.
Geriatr Gerontol Int
. 2023 Nov;
23(12):969-970.
PMID: 37967853
No abstract available.
5.
Morishima Y, Watanabe-Okochi N, Kai S, Azuma F, Kimura T, Matsumoto K, et al.
Transplant Cell Ther
. 2023 Aug;
29(10):622-631.
PMID: 37536453
In Japan, only single-unit cord blood transplantations (CBTs) are typically performed, and their number has increased over the last 23 years, with ongoing improvement in results. In most cases, CBTs...
6.
Tamaki M, Akahoshi Y, Okada Y, Uchida N, Tanaka M, Doki N, et al.
Cytotherapy
. 2023 Jun;
25(11):1220-1228.
PMID: 37341665
Background Aims: Allogeneic hematopoietic stem cell transplantation from female donors to male recipients (female-to-male allo-HCT) is a well-established risk factor for a greater incidence of non-relapse mortality (NRM) and chronic...
7.
Konuma T, Itonaga H, Ishiyama K, Doki N, Uchida N, Sawa M, et al.
Bone Marrow Transplant
. 2023 May;
58(8):893-906.
PMID: 37156881
Human leukocyte antigen (HLA)-matched sibling donors (MSDs) are the preferred choice for allogeneic hematopoietic cell transplantation (HCT). However, as myelodysplastic syndrome (MDS) is most frequently diagnosed in the elderly, MSDs...
8.
Shibata S, Arai Y, Kondo T, Mizuno S, Harada K, Miyakoshi S, et al.
Transplant Cell Ther
. 2023 Feb;
29(5):332.e1-332.e11.
PMID: 36796517
The alkylating agent busulfan is commonly used as conditioning in allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia (AML). However, a consensus has not yet been reached regarding the...
9.
Matsuda K, Konuma T, Fuse K, Masuko M, Kawamura K, Hirayama M, et al.
Br J Haematol
. 2022 Oct;
201(1):106-113.
PMID: 36281887
Allogeneic haematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for some patients with acute myeloid leukaemia (AML) who are refractory to chemotherapy. Cord blood transplantation (CBT) is a...
10.
Konuma T, Harada K, Kondo T, Masuko M, Uchida N, Yano S, et al.
Bone Marrow Transplant
. 2022 Oct;
57(12):1848-1850.
PMID: 36195770
No abstract available.